Targeting inhibition of the inflammatory response: advances in the treatment of myocardial fibrosis with natural medicine and active ingredients
Myocardial fibrosis is a critical pathological foundation of cardiovascular diseases and a fundamental process underlying myocardial remodeling. The inflammatory response is a key driver of myocardial fibrosis, promoting the proliferation of myocardial fibroblasts and collagen deposition through the...
Saved in:
| Main Authors: | Chang Shu, Chunzhen Ren, Qilin Chen, Yanyun Wang, Ruochen Li, Yue Zhang, Shuyu Yang, Ci Wang, Yingdong Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1627255/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determinants of myocardial fibrosis in patients with immune-mediated inflammatory diseases
by: Nicholas Black, et al.
Published: (2025-06-01) -
Systemic inflammation is associated with myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy
by: Xinli Guo, et al.
Published: (2025-02-01) -
Quantitative evaluation of fibrosis in idiopathic orbital inflammatory pseudotumor by IVIM-DWI
by: Jian Pu, et al.
Published: (2025-05-01) -
Navarixin alleviates cardiac remodeling after myocardial infarction by decreasing neutrophil infiltration and the inflammatory response
by: Peikun Hu, et al.
Published: (2025-03-01) -
Echocardiographic correlates of cardiac fibrosis in patients with myocardial infarction and preserved left ventricular ejection fraction
by: N. V. Fedorova, et al.
Published: (2019-06-01)